18Jan 2023
Identification of hub biomarkers and exploring the roles of immunity, M6A, ferroptosis, or cuproptosis in rats with diabetic erectile dysfunction

Identification of hub biomarkers and exploring the roles of immunity, M6A, ferroptosis, or cuproptosis in rats with diabetic erectile dysfunction

Patients with diabetic erectile dysfunction (DMED) are not satisfied with the effects of first‐line phosphodiesterase type 5 inhibitors (PDE5Is). Hence, this article was designed to mine hub biomarkers in DMED and explore its potential mechanisms. This study identified Sparc, Lox, Srebf1, and Mmp3 as potential hub biomarkers in the SD rats DMED model for future drug development and found its significant associations with m6A regulators and ferroptosis, but not with immunity or cuproptosis.

  • #urology

Like

Save

Share